Identification of New Genetic Clusters in Glioblastoma Multiforme: <i>EGFR</i> Status and <i>ADD3 </i>Losses Influence Prognosis
Glioblastoma multiforme (GB) is one of the most aggressive tumors. Despite continuous efforts to improve its clinical management, there is still no strategy to avoid a rapid and fatal outcome. <i>EGFR</i> amplification is the most characteristic alteration of these tumors. Although effec...
Main Authors: | Lara Navarro, Teresa San-Miguel, Javier Megías, Nuria Santonja, Silvia Calabuig, Lisandra Muñoz-Hidalgo, Pedro Roldán, Miguel Cerdá-Nicolás, Concha López-Ginés |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/11/2429 |
Similar Items
-
The Status of <i>EGFR</i> Modulates the Effect of miRNA-200c on <i>ZEB1</i> Expression and Cell Migration in Glioblastoma Cells
by: Lisandra Muñoz-Hidalgo, et al.
Published: (2021-12-01) -
Energy Metabolism in <i>IDH1</i> Wild-Type and <i>IDH1</i>-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
by: Cornelis J.F. van Noorden, et al.
Published: (2021-03-01) -
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
by: Arne Christians, et al.
Published: (2019-10-01) -
Molecular classification of glioblastoma based on immunohistochemical expression of EGFR, PDGFRA, NF1, IDH1, p53 and PTEN proteins
by: Sylwia Jankowska, et al.
Published: (2021-05-01) -
Dynamic Evaluation of Circulating miRNA Profile in <i>EGFR</i>-Mutated NSCLC Patients Treated with EGFR-TKIs
by: Alessandro Leonetti, et al.
Published: (2021-06-01)